Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
54.15
+0.54 (1.01%)
At close: Sep 4, 2026
| Market Cap | 3.61B -28.3% |
| Revenue (ttm) | 400.85M +27.6% |
| Net Income | 122.41M +30.6% |
| EPS | 1.82 +28.0% |
| Shares Out | 66.70M |
| PE Ratio | 29.78 |
| Forward PE | n/a |
| Dividend | 0.70 (1.31%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 1,273,591 |
| Open | 53.60 |
| Previous Close | 53.61 |
| Day's Range | 53.60 - 55.58 |
| 52-Week Range | 44.88 - 92.00 |
| Beta | -0.05 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |